{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:47:58Z","timestamp":1790668078815,"version":"4.1.0"},"reference-count":46,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol Psychiatr Sci"],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S2045796020000037_sec_a1\" sec-type=\"other\"><jats:title>Aims<\/jats:title><jats:p>Prescription opioid misuse (POM) contributes to a larger opioid crisis in the US and Canada, with over 17 000 US POM-related overdose deaths in 2017. Our aims were to (1) identify specific profiles of respondents based on POM motives using the US National Survey on Drug Use and Health (NSDUH) and (2) compare profile respondents on sociodemographics, substance use and mental and physical health outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"S2045796020000037_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>Analyses included 2017\u201318 NSDUH respondents with data on POM motives (<jats:italic>n<\/jats:italic>= 4810). POM was defined as prescription opioid use in a way not intended by the prescriber, including use without a prescription, in larger amounts or more frequently. Nine POM motives for the most recent episode were assessed, including \u2018to relieve physical pain\u2019 and \u2018to get high\u2019. Latent classes, based on POM motives, were estimated. Classes were compared on sociodemographics, substance use and physical and mental health outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"S2045796020000037_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Eight latent classes were identified (in order of prevalence): pain relief only, relax-pain relief, sleep-pain relief, multi-motive, high, experimenter, emotional coping and dependent\/hooked. Compared to the pain relief only group, the high and multi-motive classes had higher odds of all substance use outcomes, with the dependent\/hooked class having higher odds on all but one outcome. Six of the eight classes had higher odds of past-year mental health treatment and suicidal ideation than the pain relief only class.<\/jats:p><\/jats:sec><jats:sec id=\"S2045796020000037_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>Screening for pain, pain conditions, problematic substance use and psychopathology are recommended in those with any POM. While those in the dependent\/hooked, multi-motive and emotional coping classes are most likely to have prescription opioid use disorder (OUD), screening for OUD symptoms in all individuals with POM is also warranted.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s2045796020000037","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T09:02:54Z","timestamp":1580288574000},"source":"Crossref","is-referenced-by-count":30,"title":["Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample"],"prefix":"10.1017","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-0496","authenticated-orcid":false,"given":"Ty S.","family":"Schepis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"De Nadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"S2045796020000037_ref46","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6709e1"},{"key":"S2045796020000037_ref45","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6712a1"},{"key":"S2045796020000037_ref43","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths \u2013 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S2045796020000037_ref42","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001241"},{"key":"S2045796020000037_ref39","doi-asserted-by":"publisher","DOI":"10.3109\/10826088309033049"},{"key":"S2045796020000037_ref44","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176344136"},{"key":"S2045796020000037_ref37","first-page":"1","article-title":"Mortality in the United States, 2017","author":"Murphy","year":"2018","journal-title":"NCHS Data Brief"},{"key":"S2045796020000037_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2012.02.004"},{"key":"S2045796020000037_ref28","first-page":"208","article-title":"Motivations for prescription drug misuse among young adults: considering social and developmental contexts","volume":"22","author":"LeClair","year":"2015","journal-title":"Drugs (Abingdon, England)"},{"key":"S2045796020000037_ref25","first-page":"31","article-title":"Issues of validity and population coverage in student surveys of drug use","volume":"57","author":"Johnston","year":"1985","journal-title":"NIDA Research Monograph"},{"key":"S2045796020000037_ref24","first-page":"17m11973","article-title":"Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults","volume":"79","author":"Han","year":"2018","journal-title":"Journal of Clinical Psychiatry"},{"key":"S2045796020000037_ref11","volume-title":"2017 National Survey on Drug Use and Health Methodological Resource Book, Section 10: Editing and Imputation Report","year":"2019a"},{"key":"S2045796020000037_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.01.019"},{"key":"S2045796020000037_ref1","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.9.02"},{"key":"S2045796020000037_ref8","volume-title":"2016 National Survey on Drug Use and Health: Methodological Resource Book, Section 8, Data Collection Final Report","year":"2017"},{"key":"S2045796020000037_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.10.004"},{"key":"S2045796020000037_ref9","volume-title":"2017 National Survey on Drug Use and Health Public Use File Codebook","year":"2018a"},{"key":"S2045796020000037_ref6","volume-title":"National Survey on Drug Use and Health (NSDUH): Summary of Methodological Studies, 1971\u20132014","year":"2014"},{"key":"S2045796020000037_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.09.021"},{"key":"S2045796020000037_ref7","volume-title":"National Survey on Drug Use and Health: 2014 and 2015 Redesign Changes","year":"2015"},{"key":"S2045796020000037_ref3","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2014.991022"},{"key":"S2045796020000037_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.01.007"},{"key":"S2045796020000037_ref23","volume-title":"Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)","author":"Grant","year":"2014"},{"key":"S2045796020000037_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.08.018"},{"key":"S2045796020000037_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2007.05.004"},{"key":"S2045796020000037_ref13","volume-title":"2018 National Survey on Drug Use and Health Public Use File Codebook","year":"2019c"},{"key":"S2045796020000037_ref38","volume-title":"NIAAA Newsletter, Winter 2004","year":"2004"},{"key":"S2045796020000037_ref14","unstructured":"Clark SL and Muth\u00e9n B (2009) Relating latent class analysis results to variables not included in the analysis. Available at https:\/\/www.statmodel.com\/download\/relatinglca.pdf (Accessed 5 February 2019)."},{"key":"S2045796020000037_ref26","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1995.10476572"},{"key":"S2045796020000037_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2016.11.005"},{"key":"S2045796020000037_ref40","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10386"},{"key":"S2045796020000037_ref18","unstructured":"Cunningham D , Flicker L , Murphy J , Aldworth J , Myers S and Kennet J (2015) Incidence and impact of controlled access situations on nonresponse. American Association for Public Opinion Research 60th Annual Conference, Miami Beach, FL."},{"key":"S2045796020000037_ref31","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711002145"},{"key":"S2045796020000037_ref12","volume-title":"2017 National Survey on Drug Use and Health: Methodological Resource Book, Section 11: Person-Level Sampling Weight Calibration","year":"2019b"},{"key":"S2045796020000037_ref32","first-page":"551","volume-title":"The Oxford Handbook of Quantitative Methods","author":"Masyn","year":"2013"},{"key":"S2045796020000037_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.005"},{"key":"S2045796020000037_ref10","volume-title":"2017 National Survey on Drug Use and Health: Methodological Summary and Definitions","year":"2018b"},{"key":"S2045796020000037_ref16","volume-title":"Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences","author":"Collins","year":"2010"},{"key":"S2045796020000037_ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508490"},{"key":"S2045796020000037_ref36","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000892"},{"key":"S2045796020000037_ref20","doi-asserted-by":"publisher","DOI":"10.1037\/ccp0000429"},{"key":"S2045796020000037_ref21","volume-title":"Fentanils and Synthetic Cannabinoids: Driving Greater Complexity Into the Drug Situation. An Update From the EU Early Warning System","year":"2018"},{"key":"S2045796020000037_ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03520.x"},{"key":"S2045796020000037_ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2009.120"},{"key":"S2045796020000037_ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2016.1268631"},{"key":"S2045796020000037_ref22","doi-asserted-by":"crossref","first-page":"Es191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician"}],"container-title":["Epidemiology and Psychiatric Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2045796020000037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T08:13:22Z","timestamp":1665648802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2045796020000037\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":46,"alternative-id":["S2045796020000037"],"URL":"https:\/\/doi.org\/10.1017\/s2045796020000037","relation":{},"ISSN":["2045-7960","2045-7979"],"issn-type":[{"value":"2045-7960","type":"print"},{"value":"2045-7979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e97"}}